NPIPB7

Model summary

A soluble nuclear scaffold that binds other proteins and assembles repressive complexes at the nuclear pore–chromatin interface. By organizing nucleoplasmic assemblies that dampen RNA polymerase II output, it likely fine-tunes transcriptional programs from within the nucleus. Its N-terminal interaction module drives multivalent binding, positioning corepressor and chromatin-modifying factors to attenuate gene expression in the nucleoplasm.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide carries IPR054697 (Nuclear pore complex interacting protein, N-terminal domain) from residues 23–253, followed by inclusion in the broader IPR009443 (Nuclear pore complex interacting protein family) spanning residues 18–414. The N-terminal module sits near the start of the chain and is embedded within the larger family signature that covers almost the entire length, indicating a single-chain scaffold specialized for nucleocytoplasmic interface biology. The absence of catalytic motifs and the presence of a dedicated N-terminal interaction domain argue that this protein functions primarily through multivalent binding rather than enzymatic chemistry. This architecture causally supports a molecular function centered on GO:0005515 protein binding.

2. 02

   From this binding-centric core, I infer how the protein influences gene regulation.

   Members of this family often sit at the nuclear pore–chromatin interface and assemble repressive complexes. A nucleoplasmic scaffold that concentrates repressors and chromatin-modifying factors can directly decrease transcriptional output from RNA polymerase II-transcribed loci. This mechanistic role aligns with GO:0000122 negative regulation of transcription by RNA polymerase II: by recruiting or stabilizing repressive assemblies at promoters and enhancers, the protein dampens transcriptional initiation and/or elongation.

3. 03

   The cellular context follows from the same architecture.

   A soluble, non-enzymatic scaffold that engages nuclear pore-associated factors and chromatin is expected to reside in the nuclear interior rather than membranes. Thus, the most parsimonious localization is the GO:0005654 nucleoplasm, consistent with a soluble nuclear pore-interacting regulator that operates away from the pore membrane core.

4. 04

   These features together suggest a mechanism: the N-terminal interaction domain nucleates assemblies that bridge nuclear pore-associated hubs and transcriptional repression pathways.

   By tethering corepressor complexes and chromatin remodelers in the nucleoplasm, the protein attenuates RNA polymerase II activity at selected gene sets. Likely partners include nuclear pore constituents that provide docking sites and nucleoplasmic repressors that execute transcriptional downregulation. I therefore hypothesize transient interactions with nuclear pore basket and cytoplasmic filament components (to position the complex), and with transcriptional corepressors and chromatin modifiers (to enforce repression). This ensemble would allow precise, pore-coupled silencing of target loci within the nucleoplasm.